NLRP3 inhibitors

The present invention relates to novel compounds # imgabs0 # having the general formula Ib wherein R1, R2, R3, R4, R5 and Z are as described herein, compositions including the compounds, and methods of using the compounds. 本发明涉及具有所述通式Ib的新型化合物#imgabs0#其中R1、R2、R3、R4、R5和Z如本文所述，包括所述化合物的组成物以及使用所述化合物的方法。...

Full description

Saved in:
Bibliographic Details
Main Authors GUBA, WOLFGANG, JAESCHKE GEORG, MESCH, SCOTT, K, TOSTOV ALEXANDER MIKHAILOVICH, BUSH LAWRENCE A
Format Patent
LanguageChinese
English
Published 29.03.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel compounds # imgabs0 # having the general formula Ib wherein R1, R2, R3, R4, R5 and Z are as described herein, compositions including the compounds, and methods of using the compounds. 本发明涉及具有所述通式Ib的新型化合物#imgabs0#其中R1、R2、R3、R4、R5和Z如本文所述，包括所述化合物的组成物以及使用所述化合物的方法。
Bibliography:Application Number: CN202280033385